TIER-PC is an adaptive model of delivering palliative care that provides the right level of care to the right patients at the right time. It represents an adap…

Advanced Heart FailureAdvanced Non-Colorectal Gastrointestinal CancerAdvanced Lung Cancer+1 more

~Estimated

~$10 – $6,250

Icahn School of Medicine at Mount SinaiNCT07391956

Phase 1

Pilot Trial of the IL-4 Receptor Antagonist Dupilumab Plus Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer

Pilot trial of the IL-4 receptor antagonist dupilumab plus pembrolizumab, paclitaxel, and carboplatin in locally advanced triple negative breast cancer (TNBC).…

Locally Advanced Triple Negative Breast CancerTNBC - Triple-Negative Breast Cancer

~Estimated

~$10 – $7,500

Rima PatelNCT06637306